We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $19.8B
1-Year Est. Return 31.12%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+31.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.8B
AUM Growth
+$2.5B
Cap. Flow
+$3.5B
Cap. Flow %
17.7%
Top 10 Hldgs %
39.03%
Holding
664
New
14
Increased
467
Reduced
94
Closed
89

Sector Composition

1 Technology 38.36%
2 Communication Services 12.13%
3 Consumer Discretionary 10.25%
4 Healthcare 6.37%
5 Consumer Staples 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
601
Cytokinetics
CYTK
$11B
-13,278
Closed -$844K
EXEL icon
602
Exelixis
EXEL
$14B
-88,708
Closed -$3.89M
GH icon
603
Guardant Health
GH
$20.7B
-8,030
Closed -$820K
GLUE icon
604
Monte Rosa Therapeutics
GLUE
$2.02B
-25,137
Closed -$394K
GMAB icon
605
Genmab
GMAB
$17.6B
-140,733
Closed -$4.33M
GTES icon
606
Gates Industrial
GTES
$6.74B
-291,891
Closed -$6.27M
HALO icon
607
Halozyme
HALO
$9.19B
-25,631
Closed -$1.72M
HCM icon
608
HUTCHMED
HCM
$1.87B
-49,573
Closed -$661K
HRI icon
609
Herc Holdings
HRI
$4.98B
-32,596
Closed -$4.84M
HYLB icon
610
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.51B
-1,690,556
Closed -$62.3M
ICLR icon
611
Icon
ICLR
$13.2B
-7,897
Closed -$1.44M
IDA icon
612
Idacorp
IDA
$8.23B
-79,408
Closed -$10M
IDYA icon
613
IDEAYA Biosciences
IDYA
$3.48B
-71,178
Closed -$2.46M
IMCR icon
614
Immunocore
IMCR
$1.77B
-22,599
Closed -$784K
IMNM icon
615
Immunome
IMNM
$2.51B
-103,585
Closed -$2.23M
IONS icon
616
Ionis Pharmaceuticals
IONS
$8.93B
-8,557
Closed -$677K
ITRI icon
617
Itron
ITRI
$3.81B
-96,566
Closed -$8.97M
JANX icon
618
Janux Therapeutics
JANX
$992M
-37,647
Closed -$520K
LEGN icon
619
Legend Biotech
LEGN
$4.32B
-92,017
Closed -$2M
LW icon
620
Lamb Weston
LW
$6.42B
-15,092
Closed -$632K
MASI
621
DELISTED
Masimo
MASI
-4,342
Closed -$565K
MDGL icon
622
Madrigal Pharmaceuticals
MDGL
$12.6B
-1,571
Closed -$915K
MIR icon
623
Mirion Technologies
MIR
$3.91B
-104,962
Closed -$2.46M
MLYS icon
624
Mineralys Therapeutics
MLYS
$2.39B
-6,463
Closed -$235K
MOD icon
625
Modine Manufacturing
MOD
$12.2B
-53,135
Closed -$7.09M

Similar funds

NEOS Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, NEOS Investment Management held 664 positions worth $19.8B, up 14% from $17.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

NEOS Investment Management deployed $3.5B of net new capital in Q1 2026, opening 14 new positions and adding to 467 existing holdings. Its largest new stake was Enbridge: 841,618 shares worth $45.5M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Caterpillar, an estimated $19M trimmed.

  • NEOS Investment Management's largest Q1 2026 buy was Enbridge: 841,618 shares worth $45.5M.
  • NEOS Investment Management added most to Walmart Inc in Q1 2026, an estimated $333M increase.
  • NEOS Investment Management's biggest Q1 2026 reduction was Caterpillar, cutting an estimated $19M.
  • NEOS Investment Management fully exited iShares Broad USD High Yield Corporate Bond ETF in Q1 2026, selling an estimated $62.6M.
  • NEOS Investment Management's ten largest holdings make up 39% of its $19.8B portfolio in Q1 2026.
  • NEOS Investment Management opened 14 new positions and closed 89 in Q1 2026.
  • NEOS Investment Management's portfolio value rose 14% quarter-over-quarter to $19.8B.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.